With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
BenevolentAI (BAI) has an opportunity for a drug discovery scientist with experience in leading drug discovery programmes from candidate nomination, through preclinical development and into clinical trials. This individual will provide overall project leadership for small molecule drug discovery programmes progressing candidate molecules into clinical trials.
As a central member of a dynamic, multi-disciplinary team of scientists passionate about aligning preclinical drug discovery with clinical requirements, you will bring your proven resilient leadership and ability to make pragmatic data driven decisions to advance our ever expanding late stage portfolio of small molecule programs. Based at our London offices off Tottenham Court Road, you will work closely with a diverse range of experts in biological sciences, chemical sciences, safety/toxicology, clinical and commercialisations teams to progress the BAI portfolio.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the ‘apply’ button and join us.
Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team think about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.
Enter your email address below to get notified whenever we find a similar job post.
Unsubscribe at any time.